CLINICAL TRIALS PROFILE FOR PREGNYL
✉ Email this page to a colleague
All Clinical Trials for PREGNYL
Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
---|---|---|---|---|---|---|
NCT00415766 ↗ | Comparison Between Recombinant Versus Urinary hCG for Ovulation Induction in High Responders | Unknown status | Eugonia | Phase 4 | 2013-06-01 | The purpose of this study is to compare the clinical outcomes of recombinant human chorionic gonadotrophin (rHCG) and urinary HCG (uHCG) in patients undergoing IVF cycles. |
NCT00415792 ↗ | Comparison Between hCG and GnRH Agonist for Ovulation Induction in Patients With High Response to IVF Drugs | Unknown status | Eugonia | Phase 4 | 2003-11-01 | hCG and GnRH agonist can be used to induce final oocyte maturation and ovulation in IVF cycles. These two approaches will be compared in this study in terms of pregnancy rates and embryological data using patients with hyper-response to IVF drugs. |
NCT00627406 ↗ | Triggering of Final Oocyte Maturation With GnRHa (Buserelin) in GnRH Antagonist Cycles | Completed | Regionshospitalet Viborg, Skive | Phase 4 | 2009-01-01 | The purpose of this study is to possibly further improve the clinical outcome and explore the incidence of OHSS in patients, who have final oocyte maturation with GnRHa (Buserelin) in GnRH antagonist IVF/ICSI cycles |
NCT00809107 ↗ | Frozen Embryo Transfer (FET) in Natural Cycles or in Natural Cycles Controlled by Human Chorionic Gonadotropin (hCG) Administration | Completed | Universitair Ziekenhuis Brussel | N/A | 2006-10-01 | The rational of the study is to assess the implantation, pregnancy and live birth rates after the transfer of frozen- thawed embryos in natural cycles with spontaneous Luteinizing Hormone (LH)/Progesterone rise or in natural cycles controlled by human chorionic gonadotropin (hCG) for final oocyte maturation and ovulation. |
NCT00823004 ↗ | Antagonist/Letrozole in Poor Responders | Completed | Yazd Research & Clinical Center for Infertility | Phase 1/Phase 2 | 2008-06-01 | Failure to respond to controlled ovarian hyperstimulation (COH) is still a major concern in assisted reproduction and there is no consensus on the ovarian stimulation choice regime for poor responders. Aim: To evaluate and compare the efficacy of a microdose GnRH agonist flare (MF) and a GnRH antagonist/letrozole (A/L) protocols in poor responders undergoing in vitro fertilization (IVF). Methods: One hundred eighty poor responder patients will be randomized to an ovarian stimulation protocol with either a MF or a letrozole and high dose FSH/hMG and flexible GnRH antagonist protocol. |
>Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for PREGNYL
Condition Name
Clinical Trial Locations for PREGNYL
Trials by Country
Clinical Trial Progress for PREGNYL
Clinical Trial Phase
Clinical Trial Sponsors for PREGNYL
Sponsor Name